Haburchak D R, Pruitt B A
Surg Clin North Am. 1978 Dec;58(6):1119-32. doi: 10.1016/s0039-6109(16)41680-4.
A diagnosis of clinical sepsis is the primary indication for administration of systemic antibiotics. Choices of antibiotics for sepsis, where cultures are unavailable, requires a knowledge of current strains in the unit where the patient resides and coverage for both Staphylococcus aureus and Pseudomonas. Dosage requirements are increased in burned patients and serum antibiotic levels must be monitored for maximal effectiveness and minimal toxicity. Localized foci of infection must be identified and eradicated with regional antibiotic therapy or surgery when possible. Gram-negative pneumonia in the patient with an inhalation injury poses special difficulties in therapy. Resistance to antibiotics must be constantly guarded against and isolation procedures followed to avoid its propagation in the burn unit. Combination drug regimens and plasmid-directed therapy may in the future slow down the acquisition of further antibiotic resistance and lead to improved salvage of severely burned patients.
临床脓毒症的诊断是全身性抗生素给药的主要指征。在无法获得培养结果的情况下,脓毒症抗生素的选择需要了解患者所在科室当前的菌株情况以及对金黄色葡萄球菌和铜绿假单胞菌的覆盖范围。烧伤患者的剂量需求会增加,必须监测血清抗生素水平以达到最大疗效和最小毒性。必须识别局部感染病灶,并尽可能通过局部抗生素治疗或手术予以根除。吸入性损伤患者的革兰氏阴性肺炎在治疗上存在特殊困难。必须始终防范抗生素耐药性,并遵循隔离程序以避免其在烧伤病房传播。联合用药方案和质粒导向治疗未来可能会减缓进一步抗生素耐药性的产生,并提高严重烧伤患者的救治成功率。